BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma.

Saved in:
Bibliographic Details
Title: BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma.
Authors: Fang SG; Department of Radiation Oncology, 71067Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; Department of Thoracic Surgery, 71067Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Xia TL; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Fu JC; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Department of Pathology, 71067Sun Yat-Sen University Cancer Center, Guangzhou, China., Li T; Department of Cancer Prevention, 71067Sun Yat-sen University Cancer Center, Guangzhou, China., Zhong Q; State Key Laboratory of Oncology in South China, Guangzhou, China., Han F; Department of Radiation Oncology, 71067Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Guangzhou, China.; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Source: Technology in cancer research & treatment [Technol Cancer Res Treat] 2022 Jan-Dec; Vol. 21, pp. 15330338221139981.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Country of Publication: United States NLM ID: 101140941 Publication Model: Print Cited Medium: Internet ISSN: 1533-0338 (Electronic) Linking ISSN: 15330338 NLM ISO Abbreviation: Technol Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first